Maridebart cafraglutide showed promising results in weight loss, offering a monthly treatment option for obesity with ...

Novo Nordisk has launched Wegovy in India, a weight-loss drug challenging Eli Lilly's Mounjaro. Available by June 2025, ...

A clinical guidance from the American College of Cardiology Solution Set Oversight Committee states that pharmacotherapy may ...

Eli Lilly's once-weekly KwikPen format for Mounjaro has been approved in India, offering an easier delivery system for type 2 ...

Data from 2019 to 2023 show 9.2% of adults with obesity reported cost-related medication adherence. June 24th 2025 Musculoskeletal Disorders in Postmenopausal Women Are Rising Worldwide ...

Employers are grappling with the ripple effect of an increasingly popular weight loss treatment. Pharmacy benefit leaders at ...

The drug works by acting on key areas of the brain involved in appetite regulation and food intake thereby reducing hunger, ...

Eli Lillys Mounjaro KwikPen gains approval in India, targeting diabetes and obesity with its dual-action formula for weight ...

Doses often need to be adjusted as patients become acclimated to taking GLP-1s, a new class of anti-obesity medication. Research has shown these medications can help adults lose an average of 15% ...

Director Steve Ayson has teamed up with Numan’s in-house creative team on this TV campaign to show the “behavioral and ...

The best way to address employers' concerns is to improve employee utilization of weight loss benefits, according to Saunders ...

Novo Nordisk launches Wegovy, its anti-obesity drug, in India. Targeting a large obese population, Wegovy aims to improve ...